Pharmacogenomics

Article	Citations
Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-Mediated SARS-CoV-2 Entry	25
Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention	25
The Inclusion of Health Data Standards in the Implementation of Pharmacogenomics Systems: A Scoping Review	24
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program	22
Potential of Whole-Genome Sequencing-Based Pharmacogenetic Profiling	20
PGxKnow: A Pharmacogenomics Educational Hololens Application of Augmented Reality and Artificial Intelligence	20
Pharmacogenomic Testing to Support Prescribing in Primary Care: a Structured Review of Implementation Models	20
Strategies and Settings of Clinical Pharmacogenetic Implementation: a Scoping Review of Pharmacogenetics Programs	19
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary	18
Pharmacogenomics of Oxycodone: A Narrative Literature Review	17
Pharmacogenomics in the Uk National Health Service: Opportunities and Challenges	16
Genetic Susceptibilities and Prediction Modeling of Carbamazepine and Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese	15
The pharmacogenetics of treatment with olanzapine	15
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role	15
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis	14
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing	14
Pharmacogenomics Education, Research and Clinical Implementation in the State of Minnesota	14
Understanding the Barriers and Enablers of Pharmacogenomic Testing in Primary Care: A Qualitative Systematic Review with Meta-Aggregation Synthesis	14
Providers’ Perspectives on the Clinical Utility of Pharmacogenomic Testing in Pediatric Patients	14
Pharmacogenetics of Anxiety and Depression in Alzheimer’s Disease	12
Therapy Response Prediction in Major Depressive Disorder: Current and Novel Genomic Markers Influencing Pharmacokinetics and Pharmacodynamics	12
Substrate Specificity of CYP2D6 Genetic Variants	12
Developing a Gene Panel for Pharmacoresistant Epilepsy: A Review of Epilepsy Pharmacogenetics	11
Evaluating the Current Level of Pharmacists’ Pharmacogenomics Knowledge and its Impact on Pharmacogenomics Implementation	11
Effect of UGT Polymorphisms on Pharmacokinetics and Adverse Reactions of Mycophenolic Acid in Kidney Transplant Patients	11

NAMPT Single-Nucleotide Polymorphism rs1319501 and Visfatin/NAMPT Affect Nitric Oxide Formation, sFlt-1 and Antihypertensive Therapy Response in Preeclampsia	10
Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites	10
The Effect of CYP2C19 Gene Polymorphism on the Eradication Rate of Helicobacter Pylori by Proton Pump Inhibitors-ContAining Regimens in As	10
The Need to Shift Pharmacogenetic Research from Candidate Gene to Genome-Wide Association Studies	10
The Effects of Sex on Pharmacogenetically Guided Drug Treatment	10
Resolving Discordant CYP2D6 Genotyping Results in Thai Subjects: Platform Limitations and Novel Haplotypes	10
Exploring Pharmacogenetic Variants for Predicting Response to Anti-TNF Therapy in Autoimmune Diseases: a Meta-Analysis	10
Pharmacogenetics of Inflammatory Bowel Disease	9
The Frequency of Rs2231142 in ABCG2  among Asian Subgroups: Implications for Personalized Rosuvastatin Dosing	9
Impact of Variants in Atp-Binding Cassette Transporters on Breast Cancer Treatment	9
miRNAs as Potential Biomarkers of Treatment Outcome in Rheumatoid Arthritis and Ankylosing Spondylitis	9
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms	9
Gender-Dependent Association of Tyms -TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity	8
Malignant Hyperthermia Susceptibility: Utilization of Genetic Results in an Electronic Medical Record to Increase Safety	8
Attitudes about Pharmacogenomic Testing Vary by Healthcare Specialty	8
Patients Carrying DPYD Variant Alleles have Increased Risk of Severe Toxicity and Related Treatment Modifications During Fluoropyrimidine Chemotherapy	8
HLA-DRB1 *16:02 is Associated with PEG-Asparaginase Hypersensitivity	8
Polymorphisms in the CYP3A5 Gene Significantly Affect the Pharmacokinetics of Sirolimus After Kidney Transplantation	8
Nonresponse to High-Dose Bupropion for Depression in a Patient Carrying CYP2B6 *6 and CYP2C19 *17 variants: a case report	8
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events	8
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing	8
Effects of SLCO1B1 on Elimination and Toxicities of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia	8
Pharmacogenetics of Clopidogrel and Warfarin in the Treatment of Cardiovascular Diseases: An Overview of Reviews	7
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population	7
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk	7
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?	7
Is Olaparib Cost Effective in Metastatic Castration-Resistant Prostate Cancer Patients with at Least one Favorable Gene Mutation in BRCA1 , BRCA2	7
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice	7
Adolescent Perceptions of Pharmacogenetic Testing	7
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy	7
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells	7
Synthesis of Major Pharmacogenomics Pretest Counseling Themes: A Multisite Comparison	7
CYP2D6 Pharmacogenetics and Risperidone: Reflections after 25 Years of Research	7
Resistance to Platinum-Based Cancer Drugs: a Special Focus on Epigenetic Mechanisms	7
Patients’ Perspectives of a Pharmacist-Provided Clinical Pharmacogenomics Service	7
Efficacy and Safety of Opioid Therapy Guided by Pharmacogenetics: A Systematic Review	6
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder	6
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management	6
Pharmacogenetic Testing in Psychiatry and Neurology: an Overview of Reviews	6
Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate	6
Predictive Association of ABCB1 C3435T Genetic Polymorphism with the Efficacy or Safety of Lopinavir and Ritonavir in COVID-19 Patients	6
Personal Genotyping and Student Outcomes in Genetic and Pharmacogenetic Teaching: a Systematic Review and Meta-Analysis	6
Pharmacogenetic Differentiation Across Latin America	6
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True	6
Methods for Actionable Gene Fusion Detection in Lung Cancer: Now and in the Future	6
Genetic Variability of CYP2D6, CYP3A4 and CYP3A5 Among the Egyptian Population	6
HLA-A*24:07 as a Potential Biomarker for Carbamazepine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Filipino Patients	6
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters	6
Novel Associations Between Cyp2B6 Polymorphisms, Perioperative Methadone Metabolism and Clinical Outcomes in Children	6
Genetic Characterization of N -acetyltransferase 2 variants in Acquired Multidrug-Resistant Tuberculosis in Indonesia	6

The Association Between HLA-B*15:02 and Phenytoin-Induced Severe Cutaneous Adverse Reactions: A Meta-Analysis	6
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate	6
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?	6
Pharmacogenomic Landscape of Covid-19 Therapies From Indian Population Genomes	6
Pharmacogenomics and Clinical Cultural Competency: Pathway to Overcome the Limitations of Race	5
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio	5
Pharmacogenomics and Prescription Opioid Use	5
Unraveling Heterogeneity of the Clinical Pharmacogenomic Guidelines in Oncology Practice Among Major Regulatory Bodies	5
Role of miRNA Gene Variants in the Susceptibility and Pharmacogenetics of Colorectal Cancer	5
Integrating Pharmacogenetic Testing Via Medication Therapy Management in an Outpatient Family Medicine Clinic	5
Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese: The Role of HLA Alleles and Other Risk Factors	5
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”	5
Engaging Pharmacogenomics in Pain Management and Opioid Selection	5
Case Report: Severe Toxicity in an African–American Patient Receiving FOLFOX Carrying Uncommon Allelic Variants in DPYD	5
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?	5
The Pharmacogenomics of Selective Serotonin Reuptake Inhibitors	5
Pharmacogenomics Education and Perceptions: is there A Gap Between Internal Medicine Resident and Attending Physicians?	5
Influence of CYP2D6 Gene Polymorphisms on the Pharmacokinetics of Aripiprazole in Healthy Chinese Subjects	5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants	5
Pharmacogenetic Evaluation of 6-Mercaptopurine-Mediated Toxicity in Pediatric Acute Lymphoblastic Leukemia Patients from a South Indian Population	5
Clinical and Genetic Risk Factors for the Prediction Of Hepatotoxicity Induced by a Docetaxel, Epirubicin and Cyclophosphamide⟒egimen in Breast Cancer Patients	4
CYP2C18: The Orphan in the CYP2C Family	4
SLCO1B1 Gene-Based Clinical Decision Support Reduces Statin-Associated Muscle Symptoms Risk With Simvastatin	4
Ending the Pharmacogenomic Gag Rule: the Imperative to Report all Results	4
Effect of CYP2D6 Genetic Polymorphism on Peak Propafenone Concentration: No Significant Effect of CYP2D6*10	4
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus	4
Evaluation of a Longitudinal Pharmacogenomics Education on Pharmacist Knowledge in a Multicampus Healthcare System	4
Systematic Review of Pharmacogenomics Knowledgebase Evidence for Pharmacogenomic Links to the Dopamine Reward Pathway for Heroin Dependence	4
Pharmacogenomics Implementation Across Multiple Clinic Settings: A Qualitative Evaluation	4
Pilot Study of Multi-Gene Pharmacogenetic Testing for Pain Management in Oncology Palliative Medicine	4
Sociodemographic Factors and Beliefs About Medicines in the Uptake of Pharmacogenomic Testing in Older Adults	4
AGO2 Expression Levels and Related Genetic Polymorphisms: Influence in Renal Cell Progression and Aggressive Phenotypes	4
Identification of Rare Defective Allelic Variants in Cases of Thiopurine S-Methyltransferase Deficient Activity	4
Pharmacogenetics Studies in Stroke Patients Treated with rtPA: a Review of the Most Interesting Findings	4
Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity	4
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients	4
Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score	4
Impact of Genetic Polymorphisms on Tacrolimus Trough Blood Concentration in Chinese Liver Transplant Recipients	4
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry	4
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka	4
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors	4
Pharmacist-Guided Pharmacogenetic Service Lowered Warfarin-Related Hospitalizations	4
Capecitabine-Induced Enterocolitis: A Case Report and Pharmacogenetic Profile	4
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide	4
Sertraline Dosing Trends in Children and Adolescents Stratified by CYP2C19 Genotype	4
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients	3
The Importance of Including African Populations in Pharmacogenetics Studies of Warfarin Response	3
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison	3
Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema	3
Negative Symptoms in Schizophrenia: Correlation with Clinical and Genetic Factors	3
Harnessing Biomarkers of Response to Improve Therapy Selection in Esophago-Gastric Adenocarcinoma	3
Breast Cancer Pharmacogenetics: A Systematic Review	3
North Carolina’s Multi-Institutional Pharmacogenomics Efforts with the North Carolina Precision Health Collaborative	3
Pan-Cancer Pharmacogenetics: Targeted Sequencing Panels or Exome Sequencing?	3
Towards Next-Generation Personalization of Tacrolimus Treatment: a Review on Advanced Diagnostic and Therapeutic Approaches	3
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study	3
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis	3
Genetic Variants of Pear1 and Ischemic Clinical Outcomes in Coronary Artery Disease Patients: a Systematic Review and Meta-Analysis	3
Molecular Pathogenesis of Hereditary Lung Cancer: a Literature Review	3
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability	3
Pharmacogenetics: Ethnicity, Treatment and Health in Latin American Populations	3
The Role of Phenoconversion in the Pharmacogenetics of Psychiatric Medication	3
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety	3
Building an Information System to Facilitate Pharmacogenomics Clinical Translation with Clinical Decision Support	3
Opportunity for Pharmacogenetics Testing in Patients with Sickle Cell Anemia	3
Effect of CYP3A5 *3 Genotypes on Lumefantrine Plasma Concentrations Among Malaria-HIV-Infected Women	3
Effects of Genetic Polymorphisms of ABCB1 on the Efficacy of Anesthetic and Analgesic Agents: a Systematic Review	3
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study	3
Implication of KDM6A in Bladder Cancer	3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases	3
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia	3
A Single-Tube Multiplex Real-Time PCR for HLA-B*38:02 Genotype by Detecting Highly Specific SNPs	3
ARG2 Single-Nucleotide Polymorphism RS3742879 Affects Plasma Arginase 2 Levels, Nitric Oxide Formation and Antihypertensive Therapy Response in Preeclampsia	3
The Role of Alcohol Intake in the Pharmacogenetics of Treatment with Clozapine	3
Interethnic Differences in Drug Response: Projected impact of Genetic Variations in the Saudi Population	3
Extending the Lymphoblastoid Cell Line Model for Drug Combination Pharmacogenomics	2
Impact of Pharmacogenomics in Achieving Personalized/Precision Medicine in the Clinical Setting: A Symposium Report	2
rs144012689 is a Highly Specific Representative Marker of HLA-B*15:02 in the Chinese Population	2
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message	2
The Search for Personalized Antidepressant Treatments: What have we Learned and Where are we Going	2

Keeping Pace with CYP2D6 Haplotype Discovery: Innovative Methods to Assign Function	2
Pharmacogenetic Testing-Guided Treatment for Oncology: An Overview of Reviews	2
The Need for a Refined Understanding of CYP2D6 in Second-Generation Antipsychotic Outcomes in Children and Adolescents	2
Congruence Rates for Pharmacogenomic Noninterruptive Alerts	2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer	2
Assessment and Clinical Utility of Pharmacogenomics by Healthcare Practitioners in North Carolina	2
The Frequency of Major ABCG2 , SLCO1B1 and CYP2C9 Variants in Asian, Native Hawaiian and Pacific Islander W	2
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis	2
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward	2
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer	2
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis	2
Heme Oxygenase-1 and Hemopexin Gene Polymorphisms and the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity in China	2
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report	2
Catalyzing Clinical Implementation of Pharmacogenomics and Personalized Medicine Interventions in Africa	2
Are There Monogenic Hereditary Forms of Bladder Cancer or Only Genetic Susceptibilities?	2
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review	2
Effect of CYP2C9 *11/*11 Genotype on Initial and Long-Term Warfarin Dose Requirement and Therapeutic Response	2
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi	2
Use of Pharmacogenetics for Benzodiazepine Prescription: State of the Art and Expectations	2
SLCO1B3 Polymorphisms and Clinical Outcomes in Kidney Transplant Recipients Receiving Mycophenolate	2
The Missing Heritability in Pharmacogenomics: Role of Nfib and Other Factors	2
Characterization of POR Haplotype Distribution in African Populations and Comparison with Other Global Populations	2
Pharmacogenomics Testing in Patients with Liver Transplant and Potential Impact on Prospective Management	2
Diagnosis and Treatment Monitoring in Breast Cancer: How Liquid Biopsy Can Support Patient Management	2
Towards More Accurate Pharmacogenomic Variant Effect Predictions	2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients	2
Indo–Swiss Symposium on Advances in Pharmacogenomic Strategies for Implementation of Personalized Medicine	2
Exploring Pharmacogenetic Difference Using Adverse Event Database: An Example of Clopidogrel and Cardiovascular Events	2
Integrating Disease and Drug-Related Phenotypes for Improved Identification of Pharmacogenomic Variants	2
Effects of Oxycodone Pharmacogenetics on Postoperative Analgesia and Related Clinical Outcomes in Children: A Pilot Prospective Study	2
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel	2
NAT2 Polymorphism and Clinical Factors that Increase Antituberculosis Drug-Induced Hepatotoxicity	2
Effects of Genetic and Nongenetic Factors on Hyperuricemia in Chinese Patients with Coronary Artery Disease	2
The Influence of TNIK Gene Polymorphisms on Risperidone Response in a Chinese Han Population	2
Frequency and Impact of DHODH, ABCG2 and CYP2C19 SNPs on the Therapeutic Efficacy, Tolerability and Toxicity of Leflunomide	2
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients	2
Effect of OPRM1/COMT Gene Polymorphisms on Sufentanil Labor Analgesia: A Cohort Study Based on Propensity Score Matching	2